MBX Earnings Mbx Biosciences, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–11 of 11
| Q1 2026 | 2026-03-31 | -0.50 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -2.38 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -1.93 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.30 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.71 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -5.82 | 2026-03-12 | 10-K |
| Q3 2025 | 2024-09-30 | -15.42 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -22.93 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -10.26 | 2025-05-12 | 10-Q |
| FY 2024 | 2023-12-31 | -31.96 | 2025-03-17 | 10-K |
| Q3 2024 | 2023-09-30 | -24.28 | 2024-11-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.